Gangliosides as regulators of cell membrane organization and functions

Advances in Experimental Medicine and Biology

Volumn 688, Issue , 2010, Pages 165-184

  Sonnino, Sandro ^b   Prinetti, Alessandro ^a  

^a Dipartimento di Chimica   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA3 INTEGRIN; CAVEOLIN 1; CD9 ANTIGEN; EPIDERMAL GROWTH FACTOR RECEPTOR; GANGLIOSIDE; GANGLIOSIDE GM3; GLYCOSPHINGOLIPID; INSULIN RECEPTOR; MEMBRANE LIPID; PLATELET DERIVED GROWTH FACTOR RECEPTOR; PROTEIN TYROSINE KINASE; SPHINGOLIPID;

ARTICLE; BLADDER TUMOR; CAVEOLA; CELL INVASION; CELL MEMBRANE; CELL MOTILITY; DEGENERATIVE DISEASE; DIMERIZATION; GLYCOSYNAPSE; HUMAN; LIPID COMPOSITION; LIPID MEMBRANE; LIPID RAFT; MALIGNANT TRANSFORMATION; MEMBRANE COMPONENT; MEMBRANE STRUCTURE; NERVE CELL DIFFERENTIATION; NONHUMAN; PHOSPHOLIPID BILAYER; PRIORITY JOURNAL; PROTEIN CARBOHYDRATE INTERACTION; PROTEIN LIPID INTERACTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; ANIMAL; BIOLOGICAL MODEL; CARBOHYDRATE ANALYSIS; CELL ADHESION; CHEMICAL STRUCTURE; CHEMISTRY; METABOLISM; MOLECULAR GENETICS; NEOPLASM; NERVOUS SYSTEM; PHYSIOLOGY; REVIEW;

ANIMALS; CARBOHYDRATE SEQUENCE; CAVEOLAE; CELL ADHESION; CELL MEMBRANE; G(M3) GANGLIOSIDE; GANGLIOSIDES; HUMANS; MEMBRANE MICRODOMAINS; MODELS, BIOLOGICAL; MOLECULAR SEQUENCE DATA; MOLECULAR STRUCTURE; NEOPLASMS; NERVOUS SYSTEM; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, INSULIN; RECEPTORS, PLATELET-DERIVED GROWTH FACTOR;

EID: 78049507803     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4419-6741-1_12     Document Type: Article

References (233)

1. Karlsson KA. On the chemistry and occurrence of sphingolipid long-chain bases. Chem Phys Lipids 1970; 5(1):6-43.
2. Schauer R. Chemistry, metabolism and biological functions of sialic acids. Adv Carbohydr Chem Biochem 1982; 40:131-234.
3. Yu RK, Ledeen RW. Gangliosides of human, bovine and rabbit plasma. J Lipid Res 1972; 13(5):680-6.
4. Kamerling JP, Vliegenthart JF. Identification of O-cetylated N-acylneuraminic acids by mass spectrometry. Carbohydr Res 1975; 41:7-17.
5. Ghidoni R, Sonnino S, Tettamanti G et al. Isolation and characterization of a trisialoganglioside from mouse brain, containing 9-O-acetyl-N- acetylneuraminic acid. J Biol Chem 1980; 255(14):6990-5.
6. Sonnino S, Ghidoni R, Chigorno V et al. Chemistry of gangliosides carrying o-acetylated sialic acid. Adv Exp Med Biol 1982; 152:55-69.
7. IUPAC-IUBMB JCoBN. Nomenclature of glycolipids. Carbohydr Res 1998; 312:167-175.
8. Feizi T. Demonstration by monoclonal antibodies that carbohydrate structures of glycoproteins and glycolipids are onco-developmental antigens. Nature 1985; 314(6006):53-7. (Pubitemid 15142022)
9. Caputto R, Maccioni AH, Caputto BL. Activation of deoxycholate solubilized adenosine triphosphatase by ganglioside and asialoganglioside preparations. Biochem Biophys Res Commun 1977; 74(3):1046-52. (Pubitemid 8040074)
10. Partington CR, Daly JW. Effect of gangliosides on adenylate cyclase activity in rat cerebral cortical membranes. Mol Pharmacol 1979; 15(3):484-91. (Pubitemid 9203065)
11. Davis CW, Daly JW. Activation of rat cerebral cortical 3',5'-cyclic nucleotide phosphodiesterase activity by gangliosides. Mol Pharmacol 1980; 17(2):206-11. (Pubitemid 10125306)
12. Leon A, Facci L, Toffano G et al. Activation of (Na+, K+)-ATPase by nanomolar concentrations of GM1 ganglioside. J Neurochem 1981; 37(2):350-7. (Pubitemid 11059448)
13. Bremer EG, Hakomori S, Bowen-Pope DF et al. Ganglioside-mediated modulation of cell growth, growth factor binding and receptor phosphorylation. J Biol Chem 1984; 259(11):6818-25. (Pubitemid 14078977)
14. Goldenring JR, Otis LC, Yu RK et al. Calcium/ganglioside-dependent protein kinase activity in rat brain membrane. J Neurochem 1985; 44(4):1229-34. (Pubitemid 15107063)
15. 2+-dependent kinase phosphorylation of rat myelin basic proteins. J Neurosci Res 1986; 15(2):159-66. (Pubitemid 16168209)
16. Kreutter D, Kim JY, Goldenring JR et al. Regulation of protein kinase C activity by gangliosides. J Biol Chem 1987; 262(4):1633-7.
17. Chan KF. Ganglioside-modulated protein phosphorylation. Partial purification and characterization of a ganglioside-inhibited protein kinase in brain. J Biol Chem 1988; 263(1):568-74.
18. Chan KF. Ganglioside-modulated protein phosphorylation in muscle. Activation of phosphorylase b kinase by gangliosides. J Biol Chem 1989; 264(31):18632-7.
19. Yates AJ, Walters JD, Wood CL et al. Ganglioside modulation of cyclic AMP-dependent protein kinase and cyclic nucleotide phosphodiesterase in vitro. J Neurochem 1989; 53(1):162-7. (Pubitemid 19158123)
20. Yates AJ, Rampersaud A. Sphingolipids as receptor modulators. An overview. Ann NY Acad Sci 1998; 845:57-71.
21. Bassi R, Chigorno V, Fiorilli A et al. Exogenous gangliosides GD1b and GD1b-lactone, stably associated to rat brain P2 subcellular fraction, modulate differently the process of protein phosphorylation. J Neurochem 1991; 57(4):1207-11. (Pubitemid 21922743)
22. Rybak S, Ginzburg I, Yavin E. Gangliosides stimulate neurite outgrowth and induce tubulin mRNA accumulation in neural cells. Biochem Biophys Res Commun 1983; 116(3):974-80. (Pubitemid 14202680)
23. Morgan JI, Seifert W. Growth factors and gangliosides: A possible new perspective in neuronal growth control. J Supramol Struct 1979; 10(2):111-24. (Pubitemid 9219226)
24. Roisen FJ, Bartfeld H, Nagele R et al. Ganglioside stimulation of axonal sprouting in vitro. Science 1981; 214(4520):577-8. (Pubitemid 12206160)
25. Tsuji S, Arita M, Nagai Y. GQ1b, a bioactive ganglioside that exhibits novel nerve growth factor (NGF)-like activities in the two neuroblastoma cell lines. J Biochem (Tokyo) 1983; 94(1):303-6. (Pubitemid 13046116)
26. Facci L, Leon A, Toffano G et al. Promotion of neuritogenesis in mouse neuroblastoma cells by exogenous gangliosides. Relationship between the effect and the cell association of ganglioside GM1. J Neurochem 1984; 42(2):299-305. (Pubitemid 14180760)
27. Glebov OO, Nichols BJ. Distribution of lipid raft markers in live cells. Biochem Soc Trans 2004; 32(Pt 5):673-5. (Pubitemid 39524349)
28. Glebov OO, Nichols BJ. Lipid raft proteins have a random distribution during localized activation of the T-cell receptor. Nat Cell Biol 2004; 6(3):238-43. (Pubitemid 38344362)
29. Lin J, Shaw AS. Getting downstream without a Raft. Cell 2005; 121(6):815-6. (Pubitemid 40806412)
30. Sonnino S, Mauri L, Chigorno V et al. Gangliosides as components of lipid membrane domains. Glycobiology 2006.
31. Lajoie P, Partridge EA, Guay G et al. Plasma membrane domain organization regulates EGFR signaling in tumor cells. J Cell Biol 2007; 179(2):341-56. (Pubitemid 350004897)
32. Guirland C, Zheng JQ. Membrane lipid rafts and their role in axon guidance. Adv Exp Med Biol 2007; 621:144-55.
33. Benarroch EE. Lipid rafts, protein scaffolds and neurologic disease. Neurology 2007; 69(16):1635-9. (Pubitemid 350287148)
34. Hanzal-Bayer MF, Hancock JF. Lipid rafts and membrane traffic. FEBS Lett 2007; 581(11):2098-104. (Pubitemid 46709907)
35. Riethmuller J, Riehle A, Grassme H et al. Membrane rafts in host-pathogen interactions. Biochim Biophys Acta 2006; 1758(12):2139-47. (Pubitemid 44879365)
36. Debruin LS, Harauz G. White matter rafting-membrane microdomains in myelin. Neurochem Res 2007; 32(2):213-28. (Pubitemid 46238867)
37. Delacour D, Jacob R. Apical protein transport. Cell Mol Life Sci 2006; 63(21):2491-505. (Pubitemid 44722380)
38. Taylor DR, Hooper NM. The prion protein and lipid rafts. Mol Membr Biol 2006; 23(1):89-99.
39. Manes S, Viola A. Lipid rafts in lymphocyte activation and migration. Mol Membr Biol 2006; 23(1):59-69.
40. Brown DA, London E. Structure and function of sphingolipid- and cholesterol-rich membrane rafts. J Biol Chem 2000; 275(23):17221-4. (Pubitemid 30430750)
41. Sonnino S, Prinetti A, Mauri L et al. Dynamic and structural properties of sphingolipids as driving forces for the formation of membrane domains. Chem Rev 2006; 106(6):2111-25.
42. Rock P, Allietta M, Young WW Jr. et al. Ganglioside GM1 and asialo-GM1 at low concentration are preferentially incorporated into the gel phase in two-component, two-phase phosphatidylcholine bilayers. Biochemistry 1991; 30(1):19-25.
43. Grant CW, Wu SH, McConnell HM. Lateral phase separations in binary lipid mixtures: Correlation between spin label and freeze-fracture electron microscopic studies. Biochim Biophys Acta 1974; 363(2):151-8.
44. Knoll W, Schmidt G, Rotzer H et al. Lateral order in binary lipid alloys and its coupling to membrane functions. Chem Phys Lipids 1991; 57(2-3):363-74.
45. Cantu L, Corti M, Sonnino S et al. Evidence for spontaneous segregation phenomena in mixed micelles of gangliosides. Chem Phys Lipids 1990; 55(3):223-9. (Pubitemid 20350448)
46. Cantú L, Corti M, Casellato R et al. Aggregation properties of GD1b, II3Neu5Ac2GgOse4Cer and of GD1b-lactone, II3(alpha-Neu5Ac-(2-8, 1-9)-alpha-Neu5Ac)GgOse4Cer, in aqueous solution. Chem Phys Lipids 1991; 60:111-118.
47. Sharom FJ, Grant CW. A model for ganglioside behaviour in cell membranes. Biochim Biophys Acta 1978; 507(2):280-93. (Pubitemid 8267427)
48. Bertoli E, Masserini M, Sonnino S et al. Electron paramagnetic resonance studies on the fluidity and surface dynamics of egg phosphatidylcholine vesicles containing gangliosides. Biochim Biophys Acta 1981; 647(2):196-202. (Pubitemid 12248509)
49. Rock P, Allietta M, Young WWJ et al. Ganglioside GM1 and asialo-GM1 at low concentration are preferentially incorporated into the gel phase in two-component, two-phase phosphatidylcholine bilayers. Biochemistry 1990; 29:8484-8490.
50. Goins B, Masserini M, Barisas BG et al. Lateral diffusion of ganglioside GM1 in phospholipid bilayer membranes. Biophys J 1986; 49(4):849-56. (Pubitemid 16074712)
51. Masserini M, Palestini P, Venerando B et al. Interactions of proteins with ganglioside-enriched microdomains on the membrane: The lateral phase separation of molecular species of GD1a ganglioside, having homogeneous long-chain base composition, is recognized by Vibrio cholerae sialidase. Biochemistry 1988; 27(20):7973-8.
52. Masserini M, Palestini P, Freire E. Influence of glycolipid oligosaccharide and long-chain base composition on the thermotropic properties of dipalmitoylphosphatidylcholine large unilamellar vesicles containing gangliosides. Biochemistry 1989; 28(12):5029-34. (Pubitemid 19162749)
53. Terzaghi A, Tettamanti G, Masserini M. Interaction of glycosphingolipids and glycoproteins: Thermotropic properties of model membranes containing GM1 ganglioside and glycophorin. Biochemistry 1993; 32(37):9722-5. (Pubitemid 23296818)
54. Palestini P, Allietta M, Sonnino S et al. Gel phase preference of ganglioside GM1 at low concentration in two-component, two-phase phosphatidylcholine bilayers depends upon the ceramide moiety. Biochim Biophys Acta 1995; 1235(2):221-30.
55. Palestini P, Masserini M, Tettamanti G. Exposure to galactose oxidase of GM1 ganglioside molecular species embedded into phospholipid vesicles. FEBS Lett 1994; 350(2-3):219-22. (Pubitemid 24268025)
56. Ferraretto A, Pitto M, Palestini P et al. Lipid domains in the membrane: Thermotropic properties of sphingomyelin vesicles containing GM1 ganglioside and cholesterol. Biochemistry 1997; 36(30):9232-6. (Pubitemid 27329508)
57. Dietrich C, Volovyk ZN, Levi M et al. Partitioning of Thy-1, GM1 and cross-linked phospholipid analogs into lipid rafts reconstituted in supported model membrane monolayers. Proc Natl Acad Sci USA 2001; 98(19):10642-7. (Pubitemid 32878674)
58. Pascher I. Molecular arrangements in sphingolipids. Conformation and hydrogen bonding of ceramide and their implication on membrane stability and permeability. Biochim Biophys Acta 1976; 455(2):433-51.
59. Sonnino S, Cantu L, Corti M et al. Aggregative properties of gangliosides in solution. Chem Phys Lipids 1994; 71(1):21-45. (Pubitemid 24161965)
60. Acquotti D, Poppe L, Dabrowski J et al. Three-dimensional structure of the oligosaccaride chain of GM1 ganglioside revealed by a distance-mapping procedure: A rotating and laboratory frame nuclear overhauser enhancement investigation of native glycolipid in dimethyl sulfoxide and in water-dodecylphosphocholine solutions. J Am Chem Soc 1990; 112:7772-7778. (Pubitemid 20355855)
61. Brocca P, Cantu L, Sonnino S. Aggregation properties of semisynthetic GD1a ganglioside (IV3Neu5AcII3Neu5AcGgOse4Cer) containing an acetyl group as acyl moiety. Chem Phys Lipids 1995; 77(1):41-9.
62. Sonnino S, Cantu L, Corti M et al. Aggregation properties of semisynthetic GM1 ganglioside (II3Neu5AcGgOse4Cer) containing an acetyl group as acyl moiety. Chem Phys Lipids 1990; 56(1):49-57.
63. Sonnino S, Cantu L, Acquotti D et al. Aggregation properties of GM3 ganglioside (II3Neu5AcLacCer) in aqueous solutions. Chem Phys Lipids 1990; 52(3-4):231-41. (Pubitemid 20082358)
64. Poppe L, van Halbeek H, Acquotti D et al. Carbohydrate dynamics at a micellar surface: GD1a headgroup transformations revealed by NMR spectroscopy. Biophys J 1994; 66(5):1642-52. (Pubitemid 24145161)
65. Brocca P, Berthault P, Sonnino S. Conformation of the oligosaccharide chain of G(M1) ganglioside in a carbohydrate-enriched surface. Biophys J 1998; 74(1):309-18. (Pubitemid 28041758)
66. Siebert HC, Reuter G, Schauer R et al. Solution conformations of GM3 gangliosides containing different sialic acid residues as revealed by NOE-based distance mapping, molecular mechanics and molecular dynamics calculations. Biochemistry 1992; 31(30):6962-71.
67. Brocca P, Acquotti D, Sonnino S. Nuclear Overhauser effect investigation on GM1 ganglioside containing N-glycolyl-neuraminic acid (II3Neu5GcGgOse4Cer). Glycoconj J 1996; 13(1):57-62. (Pubitemid 26074302)
68. Scarsdale JN, Prestegard JH, Yu RK. NMR and computational studies of interactions between remote residues in gangliosides. Biochemistry 1990; 29(42):9843-55. (Pubitemid 20348518)
69. Levery SB. 1H-NMR study of GM2 ganglioside: Evidence that an interresidue amide-carboxyl hydrogen bond contributes to stabilization of a preferred conformation. Glycoconj J 1991; 8(6):484-92.
70. Acquotti D, Fronza G, Ragg E et al. Three dimensional structure of GD1b and GD1b-monolactone gangliosides in dimethylsulphoxide: A nuclear Overhauser effect investigation supported by molecular dynamics calculations. Chem Phys Lipids 1991; 59(2):107-25.
71. Acquotti D, Cantu L, Ragg E et al. Geometrical and conformational properties of ganglioside GalNAc-GD1a, IV4GalNAcIV3Neu5AcII3Neu5AcGgOse4Cer. Eur J Biochem 1994; 225(1):271-88. (Pubitemid 24306252)
72. Prinetti A, Chigorno V, Prioni S et al. Changes in the lipid turnover, composition and organization, as sphingolipid-enriched membrane domains, in rat cerebellar granule cells developing in vitro. J Biol Chem 2001; 276(24):21136-45.
73. Simons K, Ikonen E. Functional rafts in cell membranes. Nature 1997; 387(6633):569-72. (Pubitemid 27248754)
74. Brown DA, Rose JK. Sorting of GPI-anchored proteins to glycolipid-enriched membrane subdomains during transport to the apical cell surface. Cell 1992; 68(3):533-44.
75. Marchesi VT, Andrews EP. Glycoproteins: Isolation from cellmembranes with lithium diiodosalicylate. Science 1971; 174(15):1247-8.
76. Chigorno V, Palestini P, Sciannamblo M et al. Evidence that ganglioside enriched domains are distinct from caveolae in MDCK II and human fibroblast cells in culture. Eur J Biochem 2000; 267(13):4187-97. (Pubitemid 30436115)
77. Sargiacomo M, Sudol M, Tang Z et al. Signal transducing molecules and glycosyl-phosphatidylinositol-linked proteins form a caveolin-rich insoluble complex in MDCK cells. J Cell Biol 1993; 122(4):789-807. (Pubitemid 23241090)
78. Zurzolo C, van't Hof W, van Meer G et al. VIP21/caveolin, glycosphingolipid clusters and the sorting of glycosylphosphatidylinositol- anchored proteins in epithelial cells. Embo J 1994; 13(1):42-53.
79. Sorice M, Parolini I, Sansolini T et al. Evidence for the existence of ganglioside-enriched plasma membrane domains in human peripheral lymphocytes. J Lipid Res 1997; 38(5):969-80. (Pubitemid 27255205)
80. Fra AM, Williamson E, Simons K et al. Detergent-insoluble glycolipid microdomains in lymphocytes in the absence of caveolae. J Biol Chem 1994; 269(49):30745-8. (Pubitemid 24377549)
81. Iwabuchi K, Nagaoka I. Lactosylceramide-enriched glycosphingolipid signaling domain mediates superoxide generation from human neutrophils. Blood 2002; 100(4):1454-64. (Pubitemid 34864305)
82. Waheed AA, Shimada Y, Heijnen HF et al. Selective binding of perfringolysin O derivative to cholesterol-rich membrane microdomains (rafts). Proc Natl Acad Sci USA 2001; 98(9):4926-31. (Pubitemid 32397059)
83. Samuel BU, Mohandas N, Harrison T et al. The role of cholesterol and glycosylphosphatidylinositolanchored proteins of erythrocyte rafts in regulating raft protein content and malarial infection. J Biol Chem 2001; 276(31):29319-29.
84. Mendez AJ, Lin G, Wade DP et al. Membrane lipid domains distinct from cholesterol/sphingomyelin- rich rafts are involved in the ABCA1-mediated lipid secretory pathway. J Biol Chem 2001; 276(5):3158-66.
85. Ledesma MD, Simons K, Dotti CG. Neuronal polarity: Essential role of protein-lipid complexes in axonal sorting. Proc Natl Acad Sci USA 1998; 95(7):3966-71. (Pubitemid 28173237)
86. Kasahara K, Sanai Y. Functional roles of glycosphingolipids in signal transduction via lipid rafts. Glycoconj J 2000; 17(3-4):153-62. (Pubitemid 32055901)
87. Shogomori H, Futerman AH. Cholera toxin is found in detergent-insoluble rafts/domains at the cell surface of hippocampal neurons but is internalized via a raft-independent mechanism. J Biol Chem 2001; 276(12):9182-8.
88. Vey M, Pilkuhn S, Wille H et al. Subcellular colocalization of the cellular and scrapie prion proteins in caveolae-like membranous domains. Proc Natl Acad Sci 1996; 93(25):14945-14949. (Pubitemid 26419075)
89. Naslavsky N, Stein R, Yanai A et al. Characterization of detergent-insoluble complexes containing the cellular prion protein and its scrapie isoform. J Biol Chem 1997; 272(10):6324-31. (Pubitemid 27118107)
90. Prinetti A, Iwabuchi K, Hakomori S. Glycosphingolipid-enriched signaling domain in mouse neuroblastoma Neuro2a cells. Mechanism of ganglioside-dependent neuritogenesis. J Biol Chem 1999; 274(30):20916-24.
91. Prinetti A, Chigorno V, Tettamanti G et al. Sphingolipid-enriched membrane domains from rat cerebellar granule cells differentiated in culture. A compositional study. J Biol Chem 2000; 275(16):11658-65. (Pubitemid 30237726)
92. Lisanti MP, Scherer PE, Vidugiriene J et al. Characterization of caveolin-rich membrane domains isolated from an endothelial-rich source: Implications for human disease. J Cell Biol 1994; 126(1):111-26. (Pubitemid 24214933)
93. Chang WJ, Ying YS, Rothberg KG et al. Purification and characterization of smooth muscle cell caveolae. J Cell Biol 1994; 126(1):127-38. (Pubitemid 24214934)
94. Kasahara K, Watanabe Y, Yamamoto T et al. Association of Src family tyrosine kinase Lyn with ganglioside GD3 in rat brain. Possible regulation of Lyn by glycosphingolipid in caveolae-like domains. J Biol Chem 1997; 272(47):29947-53.
95. Madore N, Smith KL, Graham CH et al. Functionally different GPI proteins are organized in different domains on the neuronal surface. EMBO J 1999; 18(24):6917-6926. (Pubitemid 30000445)
96. Parkin ET, Turner AJ, Hooper NM. Amyloid precursor protein, although partially detergent-insoluble in mouse cerebral cortex, behaves as an atypical lipid raft protein. Biochem J 1999; 344(Pt 1):23-30.
97. Kawabuchi M, Satomi Y, Takao T et al. Transmembrane phosphoprotein Cbp regulates the activities of Src-family tyrosine kinases. Nature 2000; 404(6781):999-1003. (Pubitemid 30243594)
98. Parkin ET, Turner AJ, Hooper NM. Differential effects of glycosphingolipids on the detergent-insolubility of the glycosylphosphatidylinositol-anchored membrane dipeptidase. Biochem J 2001; 358(Pt 1):209-16. (Pubitemid 32778115)
99. Kubler E, Dohlman HG, Lisanti MP. Identification of Triton X-100 insoluble membrane domains in the yeast Saccharomyces cerevisiae. Lipid requirements for targeting of heterotrimeric G-protein subunits. J Biol Chem 1996; 271(51):32975-80.
100. Zhang X, Thompson GA, Jr. An apparent association between glycosylphosphatidylinositol-anchored proteins and a sphingolipid in Tetrahymena mimbres. Biochem J 1997; 323(Pt 1):197-206. (Pubitemid 27153894)
101. Taylor CM, Coetzee T, Pfeiffer SE. Detergent-insoluble glycosphingolipid/cholesterol microdomains of the myelin membrane. J Neurochem 2002; 81(5):993-1004. (Pubitemid 34809281)
102. Loberto N, Prioni S, Bettiga A et al. The membrane environment of endogenous cellular prion protein in primary rat cerebellar neurons. J Neurochem 2005; 95(3):771-83. (Pubitemid 41567169)
103. Song KS, Li S, Okamoto T et al. Copurification and direct interaction of Ras with caveolin, an integral membrane protein of caveolae microdomains. Detergent-free purification of caveolae microdomains. J Biol Chem 1996; 271(16):9690-7.
104. Smart EJ, Ying YS, Mineo C et al. A detergent-free method for purifying caveolae membrane from tissue culture cells. Proc Natl Acad Sci USA 1995; 92(22):10104-8.
105. Iwabuchi K, Yamamura S, Prinetti A et al. GM3-enriched microdomain involved in cell adhesion and signal transduction through carbohydrate- carbohydrate interaction in mouse melanoma B16 cells. J Biol Chem 1998; 273(15):9130-8. (Pubitemid 28176203)
106. Kasahara K, Watanabe K, Takeuchi K et al. Involvement of gangliosides in glycosylphosphatidylinositol- anchored neuronal cell adhesion molecule TAG-1 signaling in lipid rafts. J Biol Chem 2000; 275(44):34701-9.
107. Liu P, Ying Y, Anderson RG. Platelet-derived growth factor activates mitogen-activated protein kinase in isolated caveolae. Proc Natl Acad Sci USA 1997; 94(25):13666-70. (Pubitemid 28009640)
108. Wu C, Butz S, Ying Y et al. Tyrosine kinase receptors concentrated in caveolae-like domains from neuronal plasma membrane. J Biol Chem 1997; 272(6):3554-9. (Pubitemid 27066859)
109. Couet J, Sargiacomo M, Lisanti MP. Interaction of a receptor tyrosine kinase, EGF-R, with caveolins. Caveolin binding negatively regulates tyrosine and serine/threonine kinase activities. J Biol Chem 1997; 272(48):30429-38. (Pubitemid 27512253)
110. Waugh MG, Lawson D, Hsuan JJ. Epidermal growth factor receptor activation is localized within low-buoyant density, noncaveolar membrane domains. Biochem J 1999; 337(Pt 3):591-7.
111. Bilderback TR, Gazula VR, Lisanti MP et al. Caveolin interacts with Trk A and p75(NTR) and regulates neurotrophin signaling pathways. J Biol Chem 1999; 274(1):257-63. (Pubitemid 29035057)
112. Silva WI, Maldonado HM, Lisanti MP et al. Identification of caveolae and caveolin in C6 glioma cells. Int J Dev Neurosci 1999; 17(7):705-14. (Pubitemid 29414819)
113. 2+-activated K+ channel alpha-subunit in Madin-Darby canine kidney cells is independent of N-glycosylation. Proc Natl Acad Sci USA 2000; 97(24):13114-9.
114. Waugh MG, Lawson D, Tan SK et al. Phosphatidylinositol 4-phosphate synthesis in immunoisolated caveolae-like vesicles and low buoyant density noncaveolar membranes. J Biol Chem 1998; 273(27):17115-21. (Pubitemid 28311747)
115. Eckert GP, Igbavboa U, Muller WE et al. Lipid rafts of purified mouse brain synaptosomes prepared with or without detergent reveal different lipid and protein domains. Brain Res 2003; 962(1-2):144-50. (Pubitemid 36126331)
116. Kim KB, Kim SI, Choo HJ et al. Two-dimensional electrophoretic analysis reveals that lipid rafts are intact at physiological temperature. Proteomics 2004; 4(11):3527-35.
117. Prinetti A, Prioni S, Chigorno V et al. Immunoseparation of sphingolipid-enriched membrane domains enriched in Src family protein tyrosine kinases and in the neuronal adhesion molecule TAG-1 by anti-GD3 ganglioside monoclonal antibody. J Neurochem 2001; 78(5):1162-7. (Pubitemid 32823165)
118. Scandroglio F, Venkata JK, Loberto N et al. Lipid content of brain, brain membrane lipid domains and neurons from acid sphingomyelinase deficient mice. J Neurochem 2008; 107(2):329-38.
119. Fiedler K, Kobayashi T, Kurzchalia TV et al. Glycosphingolipid-enriched, detergent-insoluble complexes in protein sorting in epithelial cells. Biochemistry 1993; 32(25):6365-73. (Pubitemid 23208819)
120. Kim T, Pfeiffer SE. Myelin glycosphingolipid/cholesterol-enriched microdomains selectively sequester the noncompact myelin proteins CNP and MOG. J Neurocytol 1999; 28(4-5):281-93. (Pubitemid 30321010)
121. Simons M, Kramer EM, Thiele C et al. Assembly of myelin by association of proteolipid protein with cholesterol- and galactosylceramide-rich membrane domains. J Cell Biol 2000; 151(1):143-54.
122. Roper K, Corbeil D, Huttner WB. Retention of prominin in microvilli reveals distinct cholesterol-based lipid micro-domains in the apical plasma membrane. Nat Cell Biol 2000; 2(9):582-92.
123. Tillack TW, Allietta M, Moran RE et al. Localization of globoside and Forssman glycolipids on erythrocyte membranes. Biochim Biophys Acta 1983; 733(1):15-24. (Pubitemid 13044836)
124. Rahmann H, Rosner H, Kortje KH et al. Ca(2+)-ganglioside-interaction in neuronal differentiation and development. Prog Brain Res 1994; 101:127-45.
125. Hakomori S, Handa K, Iwabuchi K et al. New insights in glycosphingolipid function: "glycosignaling domain," a cell surface assembly of glycosphingolipids with signal transducer molecules, involved in cell adhesion coupled with signaling. Glycobiology 1998; 8(10):xi-xix.
126. Iwabuchi K, Prinetti A, Sonnino S et al. Involvement of very long fatty acid-containing lactosylceramide in lactosylceramide-mediated superoxide generation and migration in neutrophils. Glycoconj J 2008; 25(4):357-74.
127. Saxton MJ, Jacobson K. Single-particle tracking: Applications to membrane dynamics. Annu Rev Biophys Biomol Struct 1997; 26:373-99. (Pubitemid 27255378)
128. Jacobson K, Sheets ED, Simson R. Revisiting the fluid mosaic model of membranes. Science 1995; 268(5216):1441-2.
129. Sheets ED, Lee GM, Simson R et al. Transient confinement of a glycosylphosphatidylinositol-anchored protein in the plasma membrane. Biochemistry 1997; 36(41):12449-58. (Pubitemid 27446668)
130. Chen Y, Lagerholm BC, Yang B et al. Methods to measure the lateral diffusion of membrane lipids and proteins. Methods 2006; 39(2):147-53. (Pubitemid 44107712)
131. Jacobson K, Mouritsen OG, Anderson RG. Lipid rafts: At a crossroad between cell biology and physics. Nat Cell Biol 2007; 9(1):7-14. (Pubitemid 46024188)
132. Jacobson K, Dietrich C. Looking at lipid rafts? Trends Cell Biol 1999; 9(3):87-91. (Pubitemid 29151783)
133. Varma R, Mayor S. GPI-anchored proteins are organized in submicron domains at the cell surface. Nature 1998; 394(6695):798-801. (Pubitemid 28391646)
134. Rao M, Mayor S. Use of Forster's resonance energy transfer microscopy to study lipid rafts. Biochim Biophys Acta 2005; 1746(3):221-33. (Pubitemid 41815018)
135. Pralle A, Keller P, Florin EL et al. Sphingolipid-cholesterol rafts diffuse as small entities in the plasma membrane of mammalian cells. J Cell Biol 2000; 148(5):997-1008.
136. Poole K, Meder D, Simons K et al. The effect of raft lipid depletion on microvilli formation in MDCK cells, visualized by atomic force microscopy. FEBS Lett 2004; 565(1-3):53-8. (Pubitemid 38595320)
137. Ishitsuka R, Sato SB, Kobayashi T. Imaging lipid rafts. J Biochem (Tokyo) 2005; 137(3):249-54. (Pubitemid 40628430)
138. Lagerholm BC, Weinreb GE, Jacobson K et al. Detecting microdomains in intact cell membranes. Annu Rev Phys Chem 2005; 56:309-36. (Pubitemid 41156881)
139. Schutz GJ, Kada G, Pastushenko VP et al. Properties of lipid microdomains in a muscle cell membrane visualized by single molecule microscopy. Embo J 2000; 19(5):892-901. (Pubitemid 30119815)
140. Wilson BS, Pfeiffer JR, Oliver JM. Observing FcepsilonRI signaling from the inside of the mast cell membrane. J Cell Biol 2000; 149(5):1131-42. (Pubitemid 30354262)
141. Brugger B, Graham C, Leibrecht I et al. The membrane domains occupied by glycosylphosphatidylinositol- anchored prion protein and Thy-1 differ in lipid composition. J Biol Chem 2004; 279(9):7530-6. (Pubitemid 38294631)
142. Sharma DK, Brown JC, Choudhury A et al. Selective stimulation of caveolar endocytosis by glycosphingolipids and cholesterol 10.1091/mbc.E04-03-0189. Mol Biol Cell 2004; 15(7):3114-3122. (Pubitemid 38850109)
143. Douglass AD, Vale RD. Single-molecule microscopy reveals plasma membrane microdomains created by protein-protein networks that exclude or trap signaling molecules in T-cells. Cell 2005; 121(6):937-50. (Pubitemid 40806424)
144. Lommerse PH, Spaink HP, Schmidt T. In vivo plasma membrane organization: Results of biophysical approaches. Biochim Biophys Acta 2004; 1664:119-131. (Pubitemid 39140985)
145. Maekawa S, Iino S, Miyata S. Molecular characterization of the detergent-insoluble cholesterol-rich membrane microdomain (raft) of the central nervous system. Biochim Biophys Acta 2003; 1610(2):261-70. (Pubitemid 36324469)
146. Suzuki T. Lipid rafts at postsynaptic sites: Distribution, function and linkage to postsynaptic density. Neurosci Res 2002; 44(1):1-9. (Pubitemid 36158698)
147. Chini B, Parenti M. G-protein coupled receptors in lipid rafts and caveolae: How, when and why do they go there? J Mol Endocrinol 2004; 32(2):325-38. (Pubitemid 38584639)
148. Prinetti A, Marano N, Prioni S et al. Association of Src-family protein tyrosine kinases with sphingolipids in rat cerebellar granule cells differentiated in culture. Glycoconj J 2000; 17(3-4):223-32. (Pubitemid 32055909)
149. Paratcha G, Ibanez CF. Lipid rafts and the control of neurotrophic factor signaling in the nervous system: Variations on a theme. Curr Opin Neurobiol 2002; 12(5):542-9. (Pubitemid 35284089)
150. Tsui-Pierchala BA, Encinas M, Milbrandt J et al. Lipid rafts in neuronal signaling and function. Trends Neurosci 2002; 25(8):412-7. (Pubitemid 34804465)
151. Nagappan G, Lu B. Activity-dependent modulation of the BDNF receptor TrkB: Mechanisms and implications. Trends Neurosci 2005; 28(9):464-71. (Pubitemid 41187795)
152. Saarma M. GDNF recruits the signaling crew into lipid rafts. Trends Neurosci 2001; 24(8):427-9. (Pubitemid 32695345)
153. Yang XL, Xiong WC, Mei L. Lipid rafts in neuregulin signaling at synapses. Life Sci 2004; 75(21):2495-504. (Pubitemid 39195256)
154. Gauthier LR, Robbins SM. Ephrin signaling: One raft to rule them all? One raft to sort them? One raft to spread their call and in signaling bind them? Life Sci 2003; 74(2-3):207-16. (Pubitemid 37357052)
155. Becher A, McIlhinney RA. Consequences of lipid raft association on G-protein-coupled receptor function. Biochem Soc Symp 2005; 72:151-64. (Pubitemid 44804743)
156. Barnett-Norris J, Lynch D, Reggio PH. Lipids, lipid rafts and caveolae: Their importance for GPCR signaling and their centrality to the endocannabinoid system. Life Sciences Targeted Lipidomics: Endocannabinoids and other Endolipid Modulators 2005; 77(14):1625-1639. (Pubitemid 41073657)
157. Tooze SA, Martens GJ, Huttner WB. Secretory granule biogenesis: Rafting to the SNARE. Trends Cell Biol 2001; 11(3):116-22. (Pubitemid 32289441)
158. Decker L, Baron W, Ffrench-Constant C. Lipid rafts: Microenvironments for integrin-growth factor interactions in neural development. Biochem Soc Trans 2004; 32(Pt 3):426-30. (Pubitemid 38813529)
159. Mineo C, James GL, Smart EJ et al. Localization of epidermal growth factor-stimulated Ras/Raf-1 interaction to caveolae membrane. J Biol Chem 1996; 271(20):11930-11935. (Pubitemid 26157268)
160. Bilderback TR, Grigsby RJ, Dobrowsky RT. Association of p75(NTR) with caveolin and localization of neurotrophin-induced sphingomyelin hydrolysis to caveolae. J Biol Chem 1997; 272(16):10922-10927.
161. Masserini M, Palestini P, Pitto M. Glycolipid-enriched caveolae and caveolae-like domains in the nervous system. J Neurochem 1999; 73(1):1-11. (Pubitemid 29289105)
162. Santuccione A, Sytnyk V, Leshchyns'ka I et al. Prion protein recruits its neuronal receptor NCAM to lipid rafts to activate p59fyn and to enhance neurite outgrowth. J Cell Biol 2005; 169(2):341-354. (Pubitemid 40656571)
163. McKerracher L. Ganglioside rafts as MAG receptors that mediate blockade of axon growth. Proc Natl Acad Sci USA 2002; 99(12):7811-3. (Pubitemid 34650959)
164. Vyas AA, Patel HV, Fromholt SE et al. Gangliosides are functional nerve cell ligands for myelin-associated glycoprotein (MAG), an inhibitor of nerve regeneration. Proc Natl Acad Sci USA 2002; 99(12):8412-7. (Pubitemid 34651066)
165. Boggs JM, Wang H, Gao W et al. A glycosynapse in myelin? Glycoconj J 2004; 21(3-4):97-110. (Pubitemid 39382656)
166. Loberto N, Prioni S, Prinetti A et al. The adhesion protein TAG-1 has a ganglioside environment in the sphingolipid-enriched membrane domains of neuronal cells in culture. J Neurochem 2003; 85(1):224-33. (Pubitemid 36389712)
167. Rivaroli A, Prioni S, Loberto N et al. Reorganization of prion protein membrane environment during low potassium-induced apoptosis in primary rat cerebellar neurons. J Neurochem 2007; 103(5):1954-67. (Pubitemid 350126621)
168. Pierchala BA, Milbrandt J, Johnson EM, Jr. Glial cell line-derived neurotrophic factor-dependent recruitment of Ret into lipid rafts enhances signaling by partitioning Ret from proteasome-dependent degradation. J Neurosci 2006; 26(10):2777-87. (Pubitemid 43357861)
169. Kasahara K, Watanabe K, Kozutsumi Y et al. Association of GPI-anchored protein TAG-1 with src-family kinase Lyn in lipid rafts of cerebellar granule cells. Neurochem Res 2002; 27(7-8):823-9.
170. Lynch SA, Brugge JS, Levine JM. Induction of altered c-src product during neural differentiation of embryonal carcinoma cells. Science 1986; 234(4778):873-6. (Pubitemid 17186276)
171. Mellstrom K, Bjelfman C, Hammerling U et al. Expression of c-src in cultured human neuroblastoma and small-cell lung carcinoma cell lines correlates with neurocrine differentiation. Mol Cell Biol 1987; 7(12):4178-84.
172. Bjelfman C, Meyerson G, Cartwright CA et al. Early activation of endogenous pp60src kinase activity during neuronal differentiation of cultured human neuroblastoma cells. Mol Cell Biol 1990; 10(1):361-70.
173. den Hertog J, Pals CE, Peppelenbosch MP et al. Receptor protein tyrosine phosphatase alpha activates pp60c-src and is involved in neuronal differentiation. Embo J 1993; 12(10):3789-98. (Pubitemid 23282755)
174. Chakraborty M, Anderson GM, Chakraborty A et al. Accumulation of high level of pp60c-srcN is an early event during GM3-antibody mediated differentiation of neuro-2a neuroblastoma cells. Brain Res 1993; 625(2):197-202. (Pubitemid 23300414)
175. Cartwright CA, Simantov R, Kaplan PL et al. Alterations in pp60c-src accompany differentiation of neurons from rat embryo striatum. Mol Cell Biol 1987; 7(5):1830-40.
176. Yu XM, Salter MW. Src, a molecular switch governing gain control of synaptic transmission mediated by N-methyl-D-aspartate receptors. Proc Natl Acad Sci USA 1999; 96(14):7697-704. (Pubitemid 29328343)
177. Foster-Barber A, Bishop JM. Src interacts with dynamin and synapsin in neuronal cells. Proc Natl Acad Sci USA 1998; 95(8):4673-7. (Pubitemid 28207972)
178. Hooper N. Roles of proteolysis and lipid rafts in the processing of the amyloid precursor protein and prion protein. Biochem Soc Trans 2005; 33:335-8. (Pubitemid 40604366)
179. Kazlauskaite J, Pinheiro TJ. Aggregation and fibrillization of prions in lipid membranes. Biochem Soc Symp 2005; 72:211-22. (Pubitemid 44804747)
180. Kojima N, Shiota M, Sadahira Y et al. Cell adhesion in a dynamic flow system as compared to static system. Glycosphingolipid-glycosphingolipid interaction in the dynamic system predominates over lectin- or integrin-based mechanisms in adhesion of B16 melanoma cells to non-activated endothelial cells. J Biol Chem 1992; 267(24):17264-17270.
181. Satoh M, Ito A, Nojiri H et al. Enhanced GM3 expression, associated with decreased invasiveness, is induced by brefeldin A in bladder cancer cells. Int J Oncol 2001; 19(4):723-731.
182. Kawamura S, Ohyama C, Watanabe R et al. Glycolipid composition in bladder tumor: A crucial role of GM3 ganglioside in tumor invasion. International Journal of Cancer 2001; 94(3):343-347. (Pubitemid 32906063)
183. Nojiri H, Yamana H, Shirouzu G et al. Glycotherapy for cancer: Remodeling of ganglioside pattern as an effective approach for cancer therapy. Cancer Detec Preven 2002; 26(2):114-120. (Pubitemid 36016908)
184. Watanabe R, Ohyama C, Aoki H et al. Ganglioside GM3 overexpression induces apoptosis and reduces malignant potential in murine bladder cancer. Cancer Res 2002; 62(13):3850-3854. (Pubitemid 34728871)
185. Ono M, Handa K, Sonnino S et al. GM3 ganglioside inhibits CD9-facilitated haptotactic cell motility: Coexpression of GM3 and CD9 is essential in the downregulation of tumor cell motility and malignancy. Biochemistry 2001; 40(21):6414-6421. (Pubitemid 32472731)
186. Ono M, Handa K, Withers DA et al. Motility inhibition and apoptosis are induced by metastasis-suppressing gene product CD82 and its analogue CD9, with concurrent glycosylation. Cancer Res 1999; 59(10):2335-2339. (Pubitemid 29242279)
187. Hakomori S. Glycosylation defining cancer malignancy: New wine in an old bottle. Proc Natl Acad Sci USA 2002; 99(16):10231-3.
188. Hakomori S. Glycosynapses: Microdomains controlling carbohydrate- dependent cell adhesion and signaling. An Acad Bras Cienc 2004; 76(3):553-572. (Pubitemid 39288941)
189. Iwabuchi K, Handa K, Hakomori S. Separation of "glycosphingolipid signaling domain" from caveolin-containing membrane fraction in mouse melanoma B16 cells and its role in cell adhesion coupled with signaling. J Biol Chem 1998; 273(50):33766-73.
190. Satoh M, Nejad FM, Ohtani H et al. Association of renal cell carcinoma antigen, disialylgalactosylgloboside, with c-Src and Rho A in clustered domains at the surface membrane. Int J Oncol 2000; 16(3):529-536.
191. Steelant WF, Kawakami Y, Ito A et al. Monosialyl-Gb5 organized with cSrc and FAK in GEM of human breast carcinoma MCF-7 cells defines their invasive properties. FEBS Letters 2002; 531(1):93-98. (Pubitemid 35232792)
192. Kawakami Y, Kawakami K, Steelant WF et al. Tetraspanin CD9 is a "proteolipid," and its interaction with alpha 3 integrin in microdomain is promoted by GM3 ganglioside, leading to inhibition of laminin-5-dependent cell motility. J Biol Chem 2002; 277(37):34349-58.
193. Miura Y, Kainuma M, Jiang H et al. Reversion of the Jun-induced oncogenic phenotype by enhanced synthesis of sialosyllactosylceramide (GM3 ganglioside). Proc Natl Acad Sci USA 2004; 101(46):16204-16209. (Pubitemid 39552823)
194. Mitsuzuka K, Handa K, Satoh M et al. A specific microdomain ("glycosynapse 3") controls phenotypic conversion and reversion of bladder cancer cells through GM3-mediated interaction of alpha3beta1 integrin with CD9. J Biol Chem 2005; 280(42):35545-53. (Pubitemid 41532746)
195. Bremer EG, Schlessinger J, Hakomori S. Ganglioside-mediated modulation of cell growth. Specific effects of GM3 on tyrosine phosphorylation of the epidermal growth factor receptor. J Biol Chem 1986; 261(5):2434-40. (Pubitemid 17205183)
196. Hanai N, Nores GA, MacLeod C et al. Ganglioside-mediated modulation of cell growth. Specific effects of GM3 and lyso-GM3 in tyrosine phosphorylation of the epidermal growth factor receptor. J Biol Chem 1988; 263(22):10915-21.
197. Song WX, Vacca MF, Welti R et al. Effects of gangliosides GM3 and De-N-acetyl GM3 on epidermal growth factor receptor kinase activity and cell growth. J Biol Chem 1991; 266(16):10174-81. (Pubitemid 21906784)
198. Zhou Q, Hakomori S, Kitamura K et al. GM3 directly inhibits tyrosine phosphorylation and de-N-acetyl-GM3 directly enhances serine phosphorylation of epidermal growth factor receptor, independently of receptor-receptor interaction. J Biol Chem 1994; 269(3):1959-65.
199. Miljan EA, Meuillet EJ, Mania-Farnell B et al. Interaction of the extracellular domain of the epidermal growth factor receptor with gangliosides. J Biol Chem 2002; 277(12):10108-13. (Pubitemid 34968121)
200. Yoon SJ, Nakayama K, Hikita T et al. Epidermal growth factor receptor tyrosine kinase is modulated by GM3 interaction with N-linked GlcNAc termini of the receptor. Proc Natl Acad Sci USA 2006; 103(50):18987-91. (Pubitemid 350002815)
201. Yoon SJ, Nakayama K, Takahashi N et al. Interaction of N-linked glycans, having multivalent GlcNAc termini, with GM3 ganglioside. Glycoconj J 2006; 23(9):639-49. (Pubitemid 44934188)
202. Ringerike T, Blystad FD, Levy FO et al. Cholesterol is important in control of EGF receptor kinase activity but EGF receptors are not concentrated in caveolae. J Cell Sci 2002; 115(6):1331-1340. (Pubitemid 34272497)
203. Roepstorff K, Thomsen P, Sandvig K et al. Sequestration of epidermal growth factor receptors in noncaveolar lipid rafts inhibits ligand binding. J Biol Chem 2002; 277(21):18954-60. (Pubitemid 34959960)
204. Pike LJ. Growth factor receptors, lipid rafts and caveolae: An evolving story. Biochim Biophys Acta 2005; 1746(3):260-73. (Pubitemid 41818991)
205. Pike LJ, Han X, Gross RW. Epidermal growth factor receptors are localized to lipid rafts that contain a balance of inner and outer leaflet lipids: A shotgun lipidomics study. J Biol Chem 2005; 280(29):26796-804. (Pubitemid 41040713)
206. Waugh MG, Minogue S, Anderson JS et al. Signalling and noncaveolar rafts. Biochem Soc Trans 2001; 29(Pt 4):509-511.
207. Wang X-Q, Sun P, Paller AS. Ganglioside induces caveolin-1 redistribution and interaction with the epidermal growth factor receptor. J Biol Chem 2002; 277(49):47028-47034. (Pubitemid 36159210)
208. Wang XQ, Sun P, Paller AS. Ganglioside GM3 blocks the activation of epidermal growth factor receptor induced by integrin at specific tyrosine sites. J Biol Chem 2003; 278(49):48770-8. (Pubitemid 41079519)
209. Gustavsson J, Parpal S, Karlsson M et al. Localization of the insulin receptor in caveolae of adipocyte plasma membrane. Faseb J 1999; 13(14):1961-71. (Pubitemid 29517626)
210. Kabayama K, Sato T, Kitamura F et al. TNFalpha-induced insulin resistance in adipocytes as a membrane microdomain disorder: Involvement of ganglioside GM3. Glycobiology 2005; 15(1):21-9. (Pubitemid 40202036)
211. Couet J, Li S, Okamoto T et al. Identification of peptide and protein ligands for the caveolin-scaffolding domain. Implications for the interaction of caveolin with caveolae-associated proteins. J Biol Chem 1997; 272(10):6525-33. (Pubitemid 27118133)
212. Kabayama K, Sato T, Saito K et al. Dissociation of the insulin receptor and caveolin-1 complex by ganglioside GM3 in the state of insulin resistance. Proc Natl Acad Sci USA 2007; 104(34):13678-83. (Pubitemid 350003380)
213. Tagami S, Inokuchi Ji J, Kabayama K et al. Ganglioside GM3 participates in the pathological conditions of insulin resistance. J Biol Chem 2002; 277(5):3085-92. (Pubitemid 34953168)
214. Veracini L, Simon V, Richard V et al. The Csk-binding protein PAG regulates PDGF-induced Src mitogenic signaling via GM1. J Cell Biol 2008; 182(3):603-14.
215. Wada T, Yoshikawa Y, Tokuyama S et al. Cloning, expression and chromosomal mapping of a human ganglioside sialidase. Biochem Biophys Res Commun 1999; 261(1):21-7. (Pubitemid 29371612)
216. Miyagi T, Wada T, Iwamatsu A et al. Molecular cloning and characterization of a plasma membrane-associated sialidase specific for gangliosides. J Biol Chem 1999; 274(8):5004-11.
217. Hasegawa T, Yamaguchi K, Wada T et al. Molecular cloning of mouse ganglioside sialidase and its increased expression in neuro2a cell differentiation. J Biol Chem 2000; 275(19):14778.
218. Kalka D, von Reitzenstein C, Kopitz J et al. The plasma membrane ganglioside sialidase cofractionates with markers of lipid rafts. Biochem Biophys Res Commun 2001; 283(4):989-93. (Pubitemid 32924678)
219. Papini N, Anastasia L, Tringali C et al. The plasma membrane-associated sialidase MmNEU3 modifies the ganglioside pattern of adjacent cells supporting its involvement in cell-to-cell interactions. J Biol Chem 2004; 279(17):16989-95. (Pubitemid 38560452)
220. Valaperta R, Chigorno V, Basso L et al. Plasma membrane production of ceramide from ganglioside GM3 in human fibroblasts. Faseb J 2006; 20(8):1227-9.
221. Preti A, Fiorilli A, Lombardo A et al. Occurrence of sialyltransferase activity in the synaptosomal membranes prepared from calf brain cortex. J Neurochem 1980; 35(2):281-96. (Pubitemid 10034400)
222. Matsui Y, Lombard D, Massarelli R et al. Surface glycosyltransferase activities during development of neuronal cell cultures. J Neurochem 1986; 46(1):144-50. (Pubitemid 16146119)
223. Durrie R, Saito M, Rosenberg A. Endogenous glycosphingolipid acceptor specificity of sialosyltransferase systems in intact Golgi membranes, synaptosomes and synaptic plasma membranes from rat brain. Biochemistry 1988; 27(10):3759-64.
224. Durrie R, Rosenberg A. Anabolic sialosylation of gangliosides in situ in rat brain cortical slices. J Lipid Res 1989; 30(8):1259-66. (Pubitemid 19213264)
225. Iwamori M, Iwamori Y. Changes in the glycolipid composition and characteristic activation of GM3 synthase in the thymus of mouse after administration of dexamethasone. Glycoconj J 2005; 22(3):119-26. (Pubitemid 41160330)
226. Mencarelli S, Cavalieri C, Magini A et al. Identification of plasma membrane associated mature beta-hexosaminidase A, active towards GM2 ganglioside, in human fibroblasts. FEBS Lett 2005; 579(25):5501-6. (Pubitemid 41455621)
227. Kong Y, Li R, Ladisch S. Natural forms of shed tumor gangliosides. Biochim Biophys Acta 1998; 1394(1):43-56. (Pubitemid 28451575)
228. Deng W, Li R, Ladisch S. Influence of cellular ganglioside depletion on tumor formation. J Natl Cancer Inst 2000; 92(11):912-7. (Pubitemid 30429191)
229. Chigorno V, Giannotta C, Ottico E et al. Sphingolipid uptake by cultured cells: Complex aggregates of cell sphingolipids with serum proteins and lipoproteins are rapidly catabolized. J Biol Chem 2005; 280(4):2668-75. (Pubitemid 40189371)
230. Schroeder F, Nemecz G, Wood WG et al. Transmembrane distribution of sterol in the human erythrocyte. Biochim Biophys Acta 1991; 1066(2):183-92.
231. Igbavboa U, Avdulov NA, Chochina SV et al. Transbilayer distribution of cholesterol is modified in brain synaptic plasma membranes of knockout mice deficient in the low-density lipoprotein receptor, apolipoprotein E, or both proteins. J Neurochem 1997; 69(4):1661-7. (Pubitemid 27406967)
232. Palestini P, Pitto M, Tedeschi G et al. Tubulin anchoring to glycolipid-enriched, detergent-resistant domains of the neuronal plasma membrane. J Biol Chem 2000; 275(14):9978-85. (Pubitemid 30202044)
233. Viola A, Gupta N. Tether and trap: Regulation of membrane-raft dynamics by actin-binding proteins. Nat Rev Immunol 2007; 7(11):889-96. (Pubitemid 350006240)